Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

MYLAN, LDA.

NIF 502248793
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €2,324,553 82 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €2,324,553 82 contracts
A2 · Late Publication €8,294,039,207 3,964 contracts
Contract published to BASE more than 10 days after the signing date
LOW €8,294,039,207 3,964 contracts
A5 · Threshold Splitting €54,757,596 123 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €54,757,596 123 contracts
A6 · Low Competition €50,460,981 23 contracts
Only one bidder participated in a competitive procedure
MEDIUM €50,460,981 23 contracts
A9 · Price Overrun €1,108 1 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €1,108 1 contracts
A9 · Abnormal Price Reduction €10,358,725,575 2,966 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €10,358,725,575 2,966 contracts
C3 · Missing Mandatory Fields €3,938,549 134 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €3,938,549 134 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

629
€589,858,012
210
€447,163,990
83
€441,720,723
82
€432,603,822
511
€423,531,450
173
€413,677,650
82
€397,743,265
367
€385,814,279
51
€354,752,201
71
€327,548,920
110
€306,836,004
136
€290,479,857
120
€276,174,798
314
€275,326,636
44
€274,584,628
51
€267,538,761
71
€263,643,601
67
€259,728,186
78
€256,883,015
158
€253,321,565
Page 1 of 4 · 69 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 3 · 123 contracts

SUNITINIB 25 MG CÁPS - POR MARCA
PT · 13064016 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€4,788 2026-01-23
Aquisição de TRAMADOL, ORAL, 50 MG, CAP, ao Lab. Mylan, para a ULSASI, para o ano de 2026
PT · 12660036 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€4,752 2026-01-19
050100122026 - C/ BASE NO CPA 2023_436 - MÁQUINA DE REEMBALAGEM - PROUD
PT · 12799203 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,471 2026-01-07
06/04325.11/2025 - Aquisição de "Carboximaltose férrica 50 mg/ml Sol inj Fr 20 ml IV" ao abrigo do Acordo quadro 2025/1303 (CC2025)
PT · 12068092 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€72,550 2025-11-14
Q1/2318/2025 - AGREGAÇÃO URGENTE - MEDICAMENTOS DO FORO ONCOLÓGICO E IMUNOMODULADORES
PT · 11976933 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€5,294,078 2025-10-22
Nota de encomenda 1687112561 - Aquisição de bens para os serviços farmacêuticos do HP
PT · 11899031 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,035 2025-09-05
Aquisição de DASATINIB 100 MG COMP e DASATINIB 50 MG COMP e DASATINIB 140 MG COMP
PT · 11672671 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€71,729 2025-09-01
ADCM3064/25 - MEDICAMENTOS DIVERSOS
PT · 11616287 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€149,723 2025-07-11
Aquisição de DCI'S, ao Lab.Mylan, para a ULSASI, para o ano de 2025
PT · 11545366 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,088 2025-06-11
Medicamentos
PT · 11561144 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,413 2025-05-15
ADCM 1762/25 - MEDICAMENTOS DIVERSOS
PT · 11484446 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,912 2025-04-14
BOSENTANO 125 MG COMP
PT · 11671182 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,476 2025-04-10
090100252025 EVEROLÍMUS COMP
PT · 11371966 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication
€74,869 2025-04-09
040104662025 - BOSENTANO 125 MG COMP
PT · 11804356 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,476 2025-04-01
PANCREATINA 60.12 MG/100 MG GRAN GR EMB 20 G ORAL
PT · 11327919 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€4,981 2025-03-28
Medicamentos diversos V
PT · 11318021 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,578 2025-02-10
VÁRIOS MEDICAMENTOS
PT · 11191927 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€71,862 2025-01-20
VÁRIOS MEDICAMENTOS
PT · 10767557 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,694 2024-06-05
VÁRIOS MEDICAMENTOS
PT · 10769824 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,694 2024-06-05
MEDICAMENTOS DIVERSOS
PT · 10769925 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€149,980 2024-05-31
ANTIVIRICOS
PT · 10745471 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€146,195 2024-05-28
Aquisição de medicação antialérgica, vitaminas e sais minerais e medicamentos usados no tratamento de intoxicações
PT · 10786044 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€143,830 2024-05-15
Medicamentos
PT · 10959460 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€4,818 2024-04-18
VÁRIOS MEDICAMENTOS
PT · 10672000 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€74,708 2024-03-12
ANTIEPILETICOS E ANTICONVULSIONANTES
PT · 10597449 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€73,446 2024-03-06
CPR 28/2023 Medicamentos do aparelho geniturinário (CP 2023/495)
PT · 10604840 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,989 2024-02-07
MEDICAMENTOS APARELHO CARDIOVASCULAR
PT · 10541399 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€149,979 2024-01-26
Aquisição de Medicamentos do aparelho digestivo ao abrigo do Acordo Quadro 2022/14 para o ano 2024
PT · 10839360 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€146,907 2024-01-25
2024000720 - FAR HOSP PL - Sugamadex 100 mg/ml Sol inj Fr 2 ml IV
PT · 10648508 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,760 2024-01-24
Aquisição de Medicamentos do Aparelho Cardiovascular
PT · 10518457 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€143,940 2024-01-18
Medicamentos do Aparelho Digestivo AQ2022/14 - ano 2024
PT · 10510335 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€144,413 2024-01-01
PA Nº187/PA/HPSJD/2023 - Aquisição de bens para os Serviços Farmacûticos do Hospital Prisional.
PT · 10407960 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,855 2023-12-12
Aquisição do Medicamento DARUNAVIR
PT · 10371248 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,440 2023-11-24
PQ/2802/2023 -MED.ANTIVIRICOS E ANTIFUGICOS
PT · 10341501 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€145,361 2023-11-13
231G001643 - AQUISIÇÃO DE PANCREATINA CAPS 150 MG
PT · 10330688 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,999 2023-11-07
ABIRATERONA 500 MG COMP
PT · 10344820 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,416 2023-10-31
Aquisição de EMTRICITABINA+TENOFOVIR 200245MG, CMP ao Lab. Mylan para o HFF para o ano de 2023
PT · 10932439 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€73,899 2023-10-19
DARUNAVIR 800 MG COMP
PT · 10328170 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€74,700 2023-10-16
MEDICAMENTOS
PT · 10295168 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€73,656 2023-10-11
D499-10109432 -DARUNAVIR 800 MG COMP - CPA 40/2022
PT · 11670171 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,924 2023-09-26
VÁRIOS MEDICAMENTOS
PT · 10259073 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,287 2023-09-22
MEDICAMENTOS
PT · 10234242 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,675 2023-09-06
ANTIMETABOLITOS - AZACITIDINA, CLADRIBINA E PEMETREXEDO - 2º SEMESTRE
PT · 10213589 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€144,618 2023-08-25
Aquisição de Tenofovir oral 245mg Comp
PT · 10291398 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,792 2023-04-18
060100682023-C/BASE NO CPA 2022_40
PT · 9901195 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,646 2023-03-29
231000111 - AQUISIÇÃO DE MEDICAMENTOS DIVERSOS - 47/2021
PT · 9833050 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€4,885 2023-02-27
EVEROLIMUS 2.5MG COMP
PT · 10201130 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,795 2023-02-27
Diversos Medicamentos 2023
PT · 9799180 · Consulta Prévia
A5 · Threshold Splitting
€74,156 2023-02-07
6100001/2023 - HIALURONATO DE SÓDIO 60 MG I ART SOL INJ
PT · 10342486 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication
€19,550 2023-01-02
ANTIBACTERIANOS - TOBRAMICINA
PT · 9621332 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,096 2022-11-25
Next →
Overview
Total Value Won
€10,411,448,187
Contracts Won
5,679
Score 199820 · CRITICAL RISK
NIF
502248793
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.D. [P-98ca]
    Gerente
    since 2021-07-16
  • A.N. [P-80ea]
    Gerente
    since 2025-12-17
  • M.G. [P-8d91]
    Sócio
    since 2019-02-11
  • M.G. [P-f234]
    Sócio
    since 2009-06-19
  • A.Z. [P-7ca1]
    Gerente
    until 2013-08-27
  • A.Z. [P-7ca1]
    Gerente
    2016-03-17 → 2023-07-07
  • J.M. [P-3c82]
    Gerente
    until 2011-08-17
  • J.M. [P-f6b7]
    Gerente
    2011-08-17 → 2021-07-16
  • L.R. [P-b234]
    Gerente
    2023-07-07 → 2024-04-03
  • M.R. [P-c003]
    Gerente
    2024-04-08 → 2025-12-17
  • S.V. [P-457a]
    Gerente
    until 2016-03-17
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned